Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Hold at Loop Capital. 2. Merit Medical (MMSI) initiated with a Buy at Needham. 3. Wingstop (WING) initiated with a Buy at BTIG. 4. Globant (GLOB) initiated with a Hold at HSBC. 5. Albireo Pharma (ALBO) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Wedbush lowered the firm's price target on Roku to $80 from $120 and keeps an Outperform rating on the shares ahead of the company reporting Q1 results after market close on Thursday, April 25. The firm expects Roku to report Q1 revenue of $855M, versus consensus of $849M and guidance of $850M, along with adjusted EBITDA of $5M, versus consensus of $3M and guidance of breakeven. However, the firm applies a lower multiple on its discounted 2030 EPS estimate, stating that while it had been previously sanguine about Roku's e-commerce opportunity, it is "less so" as it became aware of some competitive disadvantages for Roku and its need to ramp investment to rise to the level of competition in the space.